10-K Decoder · All companies

AnaptysBio, Inc.

ANAB · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Mar 2026

Open the dashboardInfographicSummary

FY2025 key figures

$FY2025FY2024Change
Revenue$235M$91.3M+157%
Operating income$47.9M−$115M
Net income−$13.2M−$145M+90.9%

Latest quarter: Q1 2026

Form 10-Q · Three months ended Mar 31, 2026 · filed May 12, 2026

$Q1 2026Year earlierChange
Revenue$25.6M$27.8M−7.9%
Operating income−$34.6M−$27.5M−25.8%
Net income−$52.9M−$39.3M−34.6%

Q1 2026 dashboardQ1 2026 infographic

Questions

What was AnaptysBio's revenue in FY2025?
$235M in FY2025 (Fiscal year ended Dec 31, 2025), +157% vs $91.3M a year earlier, per its 10-K filed Mar 2026.
Was AnaptysBio profitable in FY2025?
No: net income was −$13.2M and operating income $47.9M in FY2025.
What was AnaptysBio's revenue in Q1 2026?
$25.6M (−7.9% vs a year earlier), per its Form 10-Q filed May 12, 2026.